- Home
- WVVI vs SONN Comparison
WVVI vs SONN Comparison
Compare WVVI & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVVI
- SONN
- Stock Information
- Founded
- WVVI 1983
- SONN N/A
- Country
- WVVI United States
- SONN United States
- Employees
- WVVI N/A
- SONN N/A
- Industry
- WVVI Beverages (Production/Distribution)
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- WVVI Consumer Staples
- SONN Health Care
- Exchange
- WVVI Nasdaq
- SONN Nasdaq
- Market Cap
- WVVI 20.4M
- SONN 32.4M
- IPO Year
- WVVI N/A
- SONN N/A
- Fundamental
- Price
- WVVI $3.49
- SONN $4.70
- Analyst Decision
- WVVI
- SONN Strong Buy
- Analyst Count
- WVVI 0
- SONN 1
- Target Price
- WVVI N/A
- SONN $20.00
- AVG Volume (30 Days)
- WVVI 9.2K
- SONN 487.2K
- Earning Date
- WVVI 11-13-2025
- SONN 12-16-2025
- Dividend Yield
- WVVI N/A
- SONN N/A
- EPS Growth
- WVVI N/A
- SONN N/A
- EPS
- WVVI N/A
- SONN N/A
- Revenue
- WVVI $38,384,350.00
- SONN $1,000,000.00
- Revenue This Year
- WVVI N/A
- SONN $5,376.22
- Revenue Next Year
- WVVI N/A
- SONN N/A
- P/E Ratio
- WVVI N/A
- SONN N/A
- Revenue Growth
- WVVI N/A
- SONN 1689.52
- 52 Week Low
- WVVI $3.17
- SONN $1.08
- 52 Week High
- WVVI $7.18
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- WVVI 41.82
- SONN 50.47
- Support Level
- WVVI $3.46
- SONN $4.42
- Resistance Level
- WVVI $3.84
- SONN $5.85
- Average True Range (ATR)
- WVVI 0.22
- SONN 0.54
- MACD
- WVVI 0.01
- SONN 0.07
- Stochastic Oscillator
- WVVI 27.15
- SONN 51.47
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.